December 5, 2017
Mylan and Aspen to launch generic Busulfex injection
Mylan and its partner, Aspen have announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose…
Pharmaceuticals, Biotechnology and Life Sciences
Mylan and its partner, Aspen have announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose…
On Tuesday, the American Society for Parenteral and Enteral Nutrition (ASPEN), and Baxter International, a global leader in nutrition therapy, announced “SmartPN,” a comprehensive collaboration providing healthcare professionals with educational tools on the appropriate use of parenteral nutrition (PN) therapy.